As countries around the globe work to get their citizen vaccinated against COVID-19, a battle over intellectual property rules has emerged at the World Trade Organization. Last year, Canada passed legislation designed to ensure that patents would not pose a barrier to securing supplies of a vaccine or treatment. A year later, developing countries around the world have looked to the WTO to develop similar standards through a waiver process that would speed up access to, and production of, vaccines. Yet the proposal has run into opposition at the WTO, including from Canada.
Thiru Balasubramaniam is the Geneva Representative of Knowledge Ecology International, where he works on IP, health, and trade issues at the WTO, WIPO, and World Health Organization. He joins the Law Bytes podcast to discuss the recent developments at the WTO, the position of developed countries such as Canada, and what this means for global access to critical vaccines.
The podcast can be downloaded here, accessed on YouTube, and is embedded below. Subscribe to the podcast via Apple Podcast, Google Play, Spotify or the RSS feed. Updates on the podcast on Twitter at @Lawbytespod.
Show Notes:
India and South Africa TRIPS Waiver Proposal
Government of Canada TRIPS Council Statement, February 2021
Credits:
Al Jazeera English, Vaccine Patent Waiver Calls: 100 Countries Push for More Equitable Access
Episode 81: Why Isn't Canada Supporting a Proposal to Help Developing Countries Gain Access to COVID-19 Vaccines?